The efficacy of the administration of recombinant human soluble thrombomodulin in patients with DIC

MLA

Hideo Wada, et al. “The Efficacy of the Administration of Recombinant Human Soluble Thrombomodulin in Patients with DIC.” International Journal of Hematology, vol. 103, Nov. 2015, pp. 173–79. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....db648e1b4d876064cbbec3be07e05e79&authtype=sso&custid=ns315887.

APA

Hideo Wada, Yoshiki Yamashita, Kohshi Ohishi, Hiroshi Imai, Kei Suzuki, Naoyuki Katayama, Shuji Isaji, Takumi Aota, Masanobu Usui, & Takeshi Matsumoto. (2015). The efficacy of the administration of recombinant human soluble thrombomodulin in patients with DIC. International Journal of Hematology, 103, 173–179.

Chicago

Hideo Wada, Yoshiki Yamashita, Kohshi Ohishi, Hiroshi Imai, Kei Suzuki, Naoyuki Katayama, Shuji Isaji, Takumi Aota, Masanobu Usui, and Takeshi Matsumoto. 2015. “The Efficacy of the Administration of Recombinant Human Soluble Thrombomodulin in Patients with DIC.” International Journal of Hematology 103 (November): 173–79. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....db648e1b4d876064cbbec3be07e05e79&authtype=sso&custid=ns315887.